1201844-87-2

Upstream product

• 1112983-31-9 N-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide 
• 2251-59-4 7-bromo-2-fluoroquinoxaline 
• 349-88-2 4-Fluorobenzenesulfonyl chloride 
• 887309-87-7 N-(5-bromo-2-chloro-pyridine-3-yl)-4-fluorobenzenesulfonamide 
• 89891-65-6 7-bromo-2-chloroquinoxaline 
• 588729-99-1 3-amino-5-bromo-2-chloropyridine 

Downstream Products

• 1201842-83-2 N-(2-chloro-5-(3-(piperidin-1-yl)quinoxalin-6-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide 
• 1201842-05-8 N-(2-chloro-5-(3-(4-isopropylpiperazin-1-yl)quinoxalin-6-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide 
• 1201842-93-4 tert-butyl 3-((7-(6-chloro-5-(4-fluorophenylsulfonamido)pyridin-3-yl)quinoxalin-2-ylamino)methyl)piperidine-1-carboxylate 
• 1201843-26-6 N-(2-chloro-5-(3-(2-methoxylethylamino)quinoxalin-6-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide 
• 1201843-19-7 N-(2-chloro-5-(3-(cyclohexylmethylamino)quinoxalin-6-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide 
• 1201843-07-3 N-(2-chloro-5-(3-(benzyl(methyl)amino)quinoxalin-6-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide 
• 1201843-05-1 N-(2-chloro-5-(3-(phenethylamino)quinoxalin-6-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide 
• 1201842-85-4 N-(2-chloro-5-(3-((2-methoxylethyl)(methyl)amino)quinoxalin-6-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide 
• 1201842-91-2 N-(2-chloro-5-(3-(4,4-difluoropiperidin-1-yl)quinoxalin-6-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide 
• 1201843-72-2 N-(2-chloro-5-(3-(2-morpholinoethylamino)quinoxalin-6-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide 
• 1201842-98-9 N-(2-chloro-5-(3-(2-(piperidin-1-yl)ethylamino)quinoxalin-6-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide 
• 1201843-17-5 N-(2-chloro-5-(3-(4-methoxypiperidin-1-yl)quinoxalin-6-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide 

Relevant academic research and scientific papers

INHIBITORS OF PI3 KINASE

The present invention relates to compounds of Formula (I), or a pharmaceutically acceptable salt thereof; methods of treating diseases or conditions, such as cancer, using the compounds; and pharmaceutical compositions containing the compounds, wherein Q, X1, X2, R1 and Z are as defined herein.